NEPHRO Flashcards

1
Q

definition of hematuria

A

presence of at least 5 RBCs per microliter of urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Heme positive without RBCs

A

presence of myoglobin or hemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hematuria within the glomerulus

A

brown, cola or tea-colored or burgundy urine
protenuria >100mg/dl via dipstick
RBC casts
deformed urinary RBCs (acanthocyte)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hematuria arising from lower urinary tract

A
gross hematuria, bright red or pink
terminal hematuria
blood clots
normal unrinary RBC morphology
minimal proteinuria on dipstick (<100mg/dL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

tea or cola colored urine, facial or body edema, hypertension and oliguria

A

acute nephritic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the most common cause of gross hematuria

A

bacterial urinary tract infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

urethral bleeding in the absence of urine associated with dysuria and blood spots on underwear after voiding which occurs in prepubertal boys

A

Urethrorrhagia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

most common chronic glomerular disease

A

IgA nephropathy (Berger disease)

*IgA deposits in mesangium often accompanied by C3 complement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

diagnosis of IgA nephropathy requires

A

renal biopsy

*mesangial proliferation that may be associated with epithelial cell crescent formation and sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the clinical manifestations of IgA nephropathy

A

gross hematuria often occurs 1-2 days of onset of an URTI or GI infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

C3 level in IgA nephropathy is

A

normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

primary treatment of IgA nephropathy

A

appropriate BP control

*other treatment: ACE inhibitors and ARB effective in reducing proteinemia and retarding rate of disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alport syndrome is caused by mutations in

A

genes coding for Type IV collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

electron miscroscopy findings in Alport syndrome

A

diffuse thickening, thinning, splitting and layering of the glomerular and tubular basement membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the clinical manifestations of Alport Syndrome

A

single or recurrent gross hematuria after URTI
progressive proteinuria exceeding 1g/24hr
bilateral sensorineural hearing loss
ocular abnormalities including anterior lenticonus, macular flecks and corneal erosions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pathognomonic of Alport syndrome

A

anterior lenticonus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

sudden onset of gross hematuria, edema, hypertension and renal insufficiency

A

Acute Poststreptococcal Glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

immunofluorescence microscopic findings in patients with PSGN

A

“lumpy bumpy” deposits of immunoglobulin and complement on the GBM and mesangium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

C3 levels in PSGN

A

low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

nephritogenic strain in PSGN

A

Group A streptococcus which posses M protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

patient develop acute nephritic syndrome after ___ weeks after streptococcal pharyngitis and ___ weeks after streptococcal pyoderma

A

1-2 weeks after pharyngitis

3-6 weeks after pyoderma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

acute phase of PSGN resolves within

A

6-8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

commonly elevated after streptococcal pharyngitis

A

ASO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

best single antibody titer to document cutaneous streptococcal infection

A

anti-DNAse B level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

treatment for PSGN

A

10 day course of Penicillin recommended to limit spread of nephritogenic organisms, antibiotic therapy does not affect the natural history of GN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

most common cause of membranous glomerulopathy worldwide

A

Malaria

  • diffuse thickening of the GBM without significant cell proliferative changes
  • in situ immune complex formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

treatment for Membranous Glomerulopathy

A

Immunosuppressive therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

also known as mesangiocapillary glomerulonephritis

A

Membranoproliferative GN

  • most common in 2nd decade of life
  • C3 levels remains persistently low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

most common type of MPGN

A

Type I

  • glomeruli have accentuated lobular pattern from diffuse mesangial expansion
  • crescents if present signify poor prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

indications for renal biopsy

A

nephrotic syndrome in an older child
significant proteinuria with microscopic hematuria
hypocomplementemia lasting >/=2 months in a child with acute nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

most important cause of morbidity and mortality in SLE

A

Glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

minimal mesangial lupus nephritis

no histologic abnormalities on light microscopy but mesangial immune deposits are present on IF or EM

A

WHO Class I nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

mesangial proliferative nephritis

A

WHO Class II nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

proliferative nephritis; <50% glomeruli involvement

A

WHO Class III nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

proliferative nephritis; >50% glomeruli involvement

A

WHO Class IV nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

membranous lupus nephritis

A

WHO Class V nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

therapy given in Lupus nephritis

A

Prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

may be given in WHO Class I or II Lupus nephritis

A

Azathioprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

most common small vessel vasculitis

A

HSP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

clinical manifestations of HSP

A

purpuric rash
arthritis
abdominal pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

when should urinalysis be requested in patients with HSP?

A

weekly in patients with HSP during period of active clinical disease and once a month for up to 6 months thereafter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

when should treatment be given to patients with HSP nephritis?

A

severe HSP nephritis

>50% crescents on biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

hallmark of Rapidly progressive GN

A

crescents in glomeruli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

characterized by pulmonary hemorrhage and glumerulonephritis

A

Goodpasture Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

treatment for Goodpasture disease

A

high dose IV methylpred, cyclophosphamide and plasmapharesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

triad of HUS

A

renal insufficiency
thrombocytopenia
microangiopathic hemolytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

most common cause of HUS

A

toxin-producing E. coli that cause prodromal acute enteritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

what are the early glomerular changes in HUS

A

thickening of capillary walls caused by swelling of endothelial cells and accumulation of fibrillary material between endothelial cells and underlying basement membrane causing narrowing of capillary lumen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

characteristic of all forms of HUS

A

microvascular injury

endothelial cell damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

prognosis in HUS

A

those with HUS not associated with diarrhea is more severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

common causes of renal vein thrombosis in infants and newborn

A
asphyxia
dehydration
shock
sepsis
congenital hypercoaguable state
maternal diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

common causes of renal vein thrombosis in older children

A
nephrotic syndrome
cyanotic heart disease
inherited hypercoaguable state 
sepsis
following kidney transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

sudden onset of gross hematuria and unilateral or bilateral flank mass

A

Renal vein thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

primary treatment for renal vein thrombosis

A

supportive care
correction of fluid and electrolytes
treatment of renal insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

treatment for patients with thrombosis of inferior vena cava

A

can require surgical thrombectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

triad of nephrotic syndrome

A

hypoalbuminemia
edema
hyperlipidemia

57
Q

nephrotic range proteinuria

A

protein excretion >40mg/m2/hr or

1st morning protein:creatinine ratio >2-3:1

58
Q

findings on kidney biopsy in patients with nephrotic syndrome

A

extensive effacement of foot process

Hallmark of nephrotic syndrome

59
Q

important features of minimal change idiopathic nephrotic syndrome

A

absence of hypertension and gross hematuria

60
Q

treatment for minimal change disease

A

6 weeks course of daily steroid treatment

61
Q

steroid resistant is defined as

A

children who continue to have proteinuria (2+ greater) after 8 weeks of steroid therapy –> diagnostic biopsy should be performed

62
Q

normal anion gap (hyperchloremic) metabolic acidosis

A

Renal tubular acidosis

63
Q

proximal RTA is also called

A

Type II

  • fanconi syndrome
  • cystinosis
  • Lowe syndrome: congenital cataracts, mental retardation and Fanconi
64
Q

what are the manifestations of Fanconi syndrome

A
LMW proteinuria
glycosuria
phosphaturia
aminoaciduria
proximal RTA
65
Q

manifestations of Type II RTA

A

growth failure in the 1st year of life

Urine pH is acidic (<5.5) because distal acidification mechanism is intact

66
Q

distal RTA is also called

A

Type I RTA

67
Q

what happens in distal RTA?

A

impaired hydrogen ion excretion hence urine PH cannot be reduced to <5.5 despite presence of acidosis

  • hypokalemia
  • hypercalciuria
68
Q

RTa type IV is also known as

A

Hyperkalemic RTA

*impaired aldosterone production or impaired renal responsiveness to aldosterone

69
Q

blood anion gap <12

A

absence of anion gap

70
Q

blood anion gap >20

A

highly suggestive of presence of anion gap

71
Q

positive anion gap suggests deficiency of

A

ammoniagenesis

72
Q

negative anion gap is consistent with

A

proximal tubule bicarbonate wasting (GI bicarbonate wasting)

73
Q

mainstay of treatment in all forms of RTA

A

bicarbonate replacement

74
Q

urine shows elevated SG (>1.020), elevated urine osmolality (UOsm >500mOsm/kg), low urine NA <20meq/L, fractional excretion of sodium (FENa <1%)

A

prerenal ARF

75
Q

urine shows SG (<1.010), low urine osmolality (UOsm <350 mOsm/kg), high urine NA >40meq/L, fractional excretion of sodium (FENa >2%)

A

intrinsic ARF

76
Q

indications for dialysis in ARF

A

volume overload with evidence of hypertension and/or pulmonary edema
persistent hyperkalemia
severe metabolic acidosis unresponsive to medical tx
neurologic symptoms
BUN >100-150 mg/dl
Calcium:phosphorus imbalance with hypocalcemic tetany

77
Q

principal extracellular cation

A

Sodium

78
Q

principal intracellular cation

A

Potassium

79
Q

positive water balance –> decreased osmolality

A

hyponatremia

80
Q

negative water balance –> increased osmolality

A

hypernatremia

81
Q

factors that promote potassium secretion

A
  1. Aldosterone
  2. Increased Na delivery to the distal nephron
  3. increased urinary flow rate
82
Q

role of kidney in acid-base balance:

reabsorption of HCO3

A

proximal tubule

83
Q

role of kidney in acid-base balance:

secretion of H+ as titratable acid and ammonium

A

Distal tubule

84
Q

characteristics of Renal tubular disorders

A
  • usually inherited
  • affected children have growth failure
  • some disorders are benign and require no therapy
  • disorders may be treated with replacement of substance being lost in the urine or removal of an offending substance or metabolite
85
Q

presence of anion gap

A

> 20
lactic acidosis
inborn errors of metabolism
ingestions

86
Q

urine anion gap <0

A

RTA type II proximal

87
Q

Urine anion gap >0

A

RTA Type I

RTA Type IV

88
Q

what are the manifestations of distal RTA (Type I)?

A

vomiting, failure to thrive, acidosis ( more severe than RTA)
Nephrocalcinosis
renal calculi
bone disease –>rickets or osteomalacia

  • nephrocalcinosis
  • hyperchloremia
  • hypercalciuria
89
Q

what is Bartter syndrome?

A

*rare form of hypokalemic metabolic alkalosis with hypercalciuria
*mutation in Na-K-Chloride contransporter
*2 types:
Antenatal
Classic
*damage at thick ascending limb
*severe hypokalemia <2.5mmol/L with metabolic acidosis

90
Q

damage at thick ascending limb

A

Bartter syndrome

91
Q

treatment for Bartter syndrome

A

*prevent/correct dehydration
*potassium supplementation –> 1-3 mEq/kg/day
*Administration of Indomethacin (type 2 are sensitive)
Type 4 resistant to Indomethacin
*Spinorolactone 10-15mg/kg/day
*may lead to chronic renal failure

92
Q

What is Gitelman’s syndrome

A
  • familial hypokalemia-hypomagnesemia
  • much common in adult
  • involves thiazide-sensitive co-transporter located in DCT; diminished NaCl transport in DCT
  • often asymptomatic
  • transient episodes of tetany and weakness usually associated with abdominal pain, vomiting and fever
  • salt-craving, musculoskeletal symptoms, constitutional symptoms
  • growth retardation is absent
93
Q

Treatment for Gitelman’s syndrome

A

best treated with Mg salts alone

94
Q

inability to concentrate urine

A

Nephrogenic Diabetes Insipidus

  • damage to collecting tubule
  • resistant to ADH
  • presents soon after birth
  • poor appetite, vomiting, FTT due to excessive water intake
  • massive polyuria, hypernatremia, volume depletion, hyperthermia, polydipsia
95
Q

laboratory findings in Nephrogenic Diabetes Insipidus

A
  • polyuria: UO >2000ml/m2/day or 40ml/kg/day
  • serum osmolality: >290 mOsm/kg
  • urine osmolality: <290 mOsm/kg
  • increased serum osmolality
  • decreased serum osmolality
96
Q

Definition of normal BP

A

Children 1-13: <90th percentile for age, sex, height

Children >/=13: <120/ <80 mmHg

97
Q

definition of elevated BP

A

Children 1-13: >90th to <95th percentile for age, sex, height
Children >/=13: 120/<80 mmHg

98
Q

definition of Stage 1 hypertension

A

Children 1-13: >95th to <95th percentile + 12mmHg or 130/80 to 139/89 mmHg (whichever is lower)
Children >/=13: 130/80 to 139/89

99
Q

definition of Stage 2 hypertension

A

Children 1-13: >95th + 12mmHg or >/=140/90mmHg (whichever is lower)
Children >/=13: >/=140/90 mmHg

100
Q

BP should be checked starting at what age

A

3 years old

101
Q

correct BP cuff size

A
  • bladder width: approx 40% of the circumference of upper arm midway between olecranon and acromion
  • bladder length: should encircle 80-100% of the circumference of upper arm
102
Q

how to use the normative BP table

A

Step 1: recognition of elevated BP

  • should be checked 3x then get average
  • determine height percentile of the child using CDC growth chart
  • use correct gender table for SBP and DBP

Step 2: evaluation of etiology
evaluate comorbidities, screen for evidence of target organ damage

103
Q

screening tests for all patients with elevated BP

A

Urinalysis
BUN, Crea,
Lipid profile
Renal ultrasound

104
Q

screening tests for obese BMI >95th percentile or adolescent

A

HBA1c
AST and ALT
Fasting lipid panel

optional: 
Fasting serum glucose
DM
TSH
Drug screen
Sleep study
CBC especially those with growth delay or abnormal renal function
105
Q

screening tests for patients with comorbid factors and BP 90th to <95th percentile; all patients with BP >/= 95th percentile

A

evaluate for target-organ damage:

Echocardiogram to identify LVH
retinal exam

106
Q

screening test for all children with persistent BP >/=95th percentile

A

ambulatory BP monitoring (ABPM)

107
Q

mainstay of therapy for children with asymptomatic mild hypertension without evidence of target-organ damage

A

Lifestyle modification

108
Q

primary therapy in obesity-related hypertension

A

weight loss

109
Q

recommended diet for adolescents and adults

A
DASH diet 
decrease sodium intake
increase potassium, calcium and magnesium containing foods
6-8 servings of whole grains/ day
4-5 servings of fruits/day
4-5 servings of vegetables/day
low fat dairy food
110
Q

risk factors for UTI

A
female gender
uncircumcised male
vesicoureteral reflux
toilet training
voiding dysfunction
obstructive uropathy
urethral instrumentation
sources of external irritation
constipation
anatomic abnormality
neuropathic bladder
sexual activity
pregnancy
111
Q

diagnosis of UTI in culture results

A

*shows >50,000cfu/ml
*single pathogen (suprapubic or catheter sample) +
UA has pyuria or bacteriuira in a symptomatic child =UTI
*in bag sample, if UA (+), patient symptomatic –> catheter sample should be obtained –> CS

112
Q

treatment for acute cystitis

A

mild or diagnosis doubtful: tx can be delayed
if tx indicated: 3-5 day course of TMP-SMX (6-12 TMP/kg/day in 2 divided doses)
Nitrofurantoin (5-7mg/kg/24hr) effective in Kleb and Enterobacter
Amoxicillin (50mg/kg/24hr) in 2 divided doses

113
Q

treatment for pyelonephritis

A

Acute Febrile UTI (7-14 days)

hospitalized: Ceftriaxone 50mg/kg/24hr or Cefepime or Cefotaxime
* Nitrofurantoin should not be used routinely in children -with febrile UTI- no significant tissue levels
* repeat urine CS not routinely needed after termination of treatment

114
Q

“bottom up” approach

A

renal sonogram plus VCUG

115
Q

“top down” approach

A

DMSA scan –> if (+) –> VCUG

116
Q

risk factors for recurrent UTI

A

age
vesicoureteral reflux
bowel bladder dysfunction

117
Q

Mainstay therapy in all forms of RTA

A

Bicarbonate replacement

118
Q

Hypokalemic hypochloremic metabolic alkalosis with hypercalciuria and salt wasting

A

Bartter syndrome

119
Q

Optimal therapy for children with ESRD

A

Kidney transplantation

120
Q

Most common complication of nephrotic syndrome

A

Infection

121
Q

In patients with isolate microscopic hematuria who are asymptomatic, what should be done?

A

Obtain atleast 3 urinalysis at 2 week period then if hematuria persists, it should be evaluated

Annual creatinine with BP monitoring

122
Q

most common cause of gross hematuria

A

bacterial UTI

123
Q

most common chronic glomerular disease in children

A

IgA nephropathy

124
Q

most common cause of persistent proteinuria in school age and adolescents

A

Orthostatic (postural) proteinuria

125
Q

most common presenting symptom of children with nephrotic syndrome

A

Edema

126
Q

most common form of glomerulonephritis

A

Postinfectious GN

127
Q

most common form of HUS

A

diarrhea associated HUS from E. coli

128
Q

most common serious bacterial infection in infants <24 months with fever without an obvious focus

A

Pyelonephritis

129
Q

most common characteristic of urinary tract obstruction

A

hydronephrosis

130
Q

most common cause of severe obstructive uropathy

A

posterior urethral valves

131
Q

most common cause of daytime incontinence

A

overactive bladder

132
Q

sign of urethral prolapse

A

bloody spotting on underwear or diaper

133
Q

most common tumor developing in an undescended testis in an adolescent or adult

A

Seminoma

134
Q

most common foreign object causing vaginal bleeding in prepubertal girls

A

toilet paper

135
Q

most common obstructive anomaly of the vagina

A

imperforate hymen

136
Q

most common cause of vaginal agesis

A

Mayer-Rokitansky-Kuster-Hauser syndrome

137
Q

most common Mullerian anomaly

A

uterine septum

138
Q

bilateral palpable flank masses in an infant with pulmonary hypoplasia, oligohydramnios, and hypertension and the absence of renal cysts by sonography of the parents

A

ARKPD